Fjällskog ML - Search Results

1

Overview on human breast cancer with focus on prognostic and predictive factors with special attention on the tumour suppressor gene p53.

Norberg T, Jansson T, Sjøgren S, Mårtensson C, Andréasson I, Fjällskog ML, Lindman H, Nordgren H, Lindgren A, Holmberg L, Bergh J. Norberg T, et al. Among authors: fjallskog ml. Acta Oncol. 1996;35 Suppl 5:96-102. doi: 10.3109/02841869609083980. Acta Oncol. 1996. PMID: 9142977 Review.

2

Cyclin B is an immunohistochemical proliferation marker which can predict for breast cancer death in low-risk node negative breast cancer.

Koliadi A, Nilsson C, Holmqvist M, Holmberg L, de La Torre M, Wärnberg F, Fjällskog ML. Koliadi A, et al. Among authors: fjallskog ml. Acta Oncol. 2010 Aug;49(6):816-20. doi: 10.3109/02841861003691937. Acta Oncol. 2010. PMID: 20307242

3

Cyclin E1 is a strong prognostic marker for death from lymph node negative breast cancer. A population-based case-control study.

Lundgren C, Ahlin C, Holmberg L, Amini RM, Fjällskog ML, Blomqvist C. Lundgren C, et al. Among authors: fjallskog ml. Acta Oncol. 2015 Apr;54(4):538-44. doi: 10.3109/0284186X.2014.965274. Epub 2014 Oct 18. Acta Oncol. 2015. PMID: 25327158

4

Inflammatory cells in node-negative breast cancer.

Löfdahl B, Ahlin C, Holmqvist M, Holmberg L, Zhou W, Fjällskog ML, Amini RM. Löfdahl B, et al. Among authors: fjallskog ml. Acta Oncol. 2012 May;51(5):680-6. doi: 10.3109/0284186X.2011.652737. Epub 2012 Jan 24. Acta Oncol. 2012. PMID: 22268578

5

Ghrelin is a prognostic marker and a potential therapeutic target in breast cancer.

Grönberg M, Ahlin C, Naeser Y, Janson ET, Holmberg L, Fjällskog ML. Grönberg M, et al. Among authors: fjallskog ml. PLoS One. 2017 Apr 18;12(4):e0176059. doi: 10.1371/journal.pone.0176059. eCollection 2017. PLoS One. 2017. PMID: 28419141 Free PMC article.

6

Cyclin A is a proliferative marker with good prognostic value in node-negative breast cancer.

Ahlin C, Zhou W, Holmqvist M, Holmberg L, Nilsson C, Jirström K, Blomqvist C, Amini RM, Fjällskog ML. Ahlin C, et al. Among authors: fjallskog ml. Cancer Epidemiol Biomarkers Prev. 2009 Sep;18(9):2501-6. doi: 10.1158/1055-9965.EPI-09-0169. Epub 2009 Aug 25. Cancer Epidemiol Biomarkers Prev. 2009. PMID: 19706846 Free article.

7

Paclitaxel-induced cytotoxicity--the effects of cremophor EL (castor oil) on two human breast cancer cell lines with acquired multidrug resistant phenotype and induced expression of the permeability glycoprotein.

Fjällskog ML, Frii L, Bergh J. Fjällskog ML, et al. Eur J Cancer. 1994;30A(5):687-90. doi: 10.1016/0959-8049(94)90546-0. Eur J Cancer. 1994. PMID: 7915908

8

Aberrant expression of cyclin E in low-risk node negative breast cancer.

Ahlin C, Gruhne B, Holmqvist M, Zetterberg A, Fjällskog ML. Ahlin C, et al. Among authors: fjallskog ml. Acta Oncol. 2008;47(8):1539-45. doi: 10.1080/02841860701856581. Acta Oncol. 2008. PMID: 18607847

9

Expression of ghrelin is correlated to a favorable outcome in invasive breast cancer.

Grönberg M, Fjällskog ML, Jirström K, Janson ET. Grönberg M, et al. Among authors: fjallskog ml. Acta Oncol. 2012 Mar;51(3):386-93. doi: 10.3109/0284186X.2011.631576. Epub 2011 Nov 9. Acta Oncol. 2012. PMID: 22067021

10

Ghrelin expression is associated with a favorable outcome in male breast cancer.

Grönberg M, Nilsson C, Markholm I, Hedenfalk I, Blomqvist C, Holmberg L, Tiensuu Janson E, Fjällskog ML. Grönberg M, et al. Among authors: fjallskog ml. Sci Rep. 2018 Sep 11;8(1):13586. doi: 10.1038/s41598-018-31783-x. Sci Rep. 2018. PMID: 30206250 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

49 results

Search Page

Filters